• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过粪便潜血试验筛查结直肠癌:人们拒绝的原因

Screening for colorectal cancer by faecal occult blood test: why people choose to refuse.

作者信息

Worthley D L, Cole S R, Esterman A, Mehaffey S, Roosa N M, Smith A, Turnbull D, Young G P

机构信息

Department of Medicine, Flinders University of South Australia, Adelaide, South Australia, Australia.

出版信息

Intern Med J. 2006 Sep;36(9):607-10. doi: 10.1111/j.1445-5994.2006.01155.x.

DOI:10.1111/j.1445-5994.2006.01155.x
PMID:16911554
Abstract

To better understand the personal barriers that limit participation in faecal occult blood test (FOBT) screening for colorectal cancer, non-participants from a recent screening initiative were sent detailed questionnaires, defining their reasons for not participating, as well as how to make screening more attractive. The important barrier was procrastination. The type of FOBT kit offered influenced the reasons for not participating. Convenient FOBT and greater general practitioner involvement may be important for optimizing community acceptance of FOBT-based screening.

摘要

为了更好地理解限制参与结直肠癌粪便潜血试验(FOBT)筛查的个人障碍,我们向最近一次筛查活动中的未参与者发送了详细问卷,以明确他们不参与的原因以及如何使筛查更具吸引力。重要的障碍是拖延。所提供的FOBT试剂盒类型影响了不参与的原因。便捷的FOBT和全科医生更多的参与对于优化基于FOBT的筛查在社区中的接受度可能很重要。

相似文献

1
Screening for colorectal cancer by faecal occult blood test: why people choose to refuse.通过粪便潜血试验筛查结直肠癌:人们拒绝的原因
Intern Med J. 2006 Sep;36(9):607-10. doi: 10.1111/j.1445-5994.2006.01155.x.
2
Determinants of participation in colorectal cancer screening with faecal occult blood testing.参与粪便潜血检测筛查结直肠癌的决定因素。
J Public Health (Oxf). 2010 Sep;32(3):395-405. doi: 10.1093/pubmed/fdp115. Epub 2009 Dec 16.
3
Better acceptance of Fecal Occult Blood Test (FOBT) for colorectal cancer screening during hospitalization.住院期间对粪便潜血试验(FOBT)用于结直肠癌筛查的接受度更高。
Z Gastroenterol. 2003 Jul;41(7):655-8. doi: 10.1055/s-2003-40544.
4
Reasons for non-compliance in colorectal cancer screening with fecal occult blood test.结直肠癌粪便潜血试验筛查中不依从的原因。
Eur J Med Res. 1998 Aug 18;3(8):397-400.
5
The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.在结直肠癌筛查方面,公众更喜欢粪便潜血试验而非结肠镜检查。
Eur J Cancer Prev. 2008 Oct;17(5):430-7. doi: 10.1097/CEJ.0b013e328305a0fa.
6
Colorectal cancer mass screening event utilising quantitative faecal occult blood test.利用定量粪便潜血试验进行的结直肠癌群体筛查活动。
Singapore Med J. 2009 Apr;50(4):348-53.
7
Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.不参与粪便潜血试验结直肠癌筛查项目的低优先级主要原因。
J Public Health (Oxf). 2008 Dec;30(4):461-5. doi: 10.1093/pubmed/fdn063. Epub 2008 Aug 20.
8
Different faecal sampling methods alter the acceptability of faecal occult blood testing: a cross sectional community survey.
Eur J Cancer. 2007 Jun;43(9):1437-44. doi: 10.1016/j.ejca.2007.03.019. Epub 2007 May 1.
9
The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).促进结直肠癌筛查对筛查利用率的影响:德国“抗击结直肠癌行动”(Aktiv gegen Darmkrebs)评估
Z Gastroenterol. 2006 Nov;44(11):1127-34. doi: 10.1055/s-2006-927082.
10
Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.科罗拉多州农村地区结直肠癌筛查的预测因素:在高平原研究网络中预防结肠癌的检测
J Rural Health. 2007 Summer;23(3):238-45. doi: 10.1111/j.1748-0361.2007.00096.x.

引用本文的文献

1
Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients.循环游离微生物DNA特征和血浆可溶性CD14水平与晚期黑色素瘤患者抗PD-1治疗的临床结局相关。
Int J Mol Sci. 2024 Dec 3;25(23):12982. doi: 10.3390/ijms252312982.
2
Decisions to decline breast screening and/or breast cancer treatment based on the potential harms of overdiagnosis and overtreatment: a qualitative study.基于过度诊断和过度治疗的潜在危害而拒绝乳房筛查和/或乳腺癌治疗的决定:一项定性研究
BMJ Open. 2024 Dec 10;14(12):e089155. doi: 10.1136/bmjopen-2024-089155.
3
Co-designing planning interventions to facilitate participation in mail-out bowel cancer screening.
合作设计规划干预措施,以促进参与邮寄式结直肠癌筛查。
BMC Public Health. 2024 Sep 5;24(1):2418. doi: 10.1186/s12889-024-19867-y.
4
Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer.miRNAs 和肠道微生物群在结直肠癌中的跨界相互作用及其非侵入性诊断和治疗意义。
Int J Mol Sci. 2023 Jun 23;24(13):10520. doi: 10.3390/ijms241310520.
5
The effect of deadlines on cancer screening completion: a randomized controlled trial.截止日期对癌症筛查完成情况的影响:一项随机对照试验。
Sci Rep. 2021 Jul 6;11(1):13876. doi: 10.1038/s41598-021-93334-1.
6
Detection of cell-free microbial DNA using a contaminant-controlled analysis framework.使用受污染控制分析框架检测无细胞微生物 DNA。
Genome Biol. 2021 Jun 23;22(1):187. doi: 10.1186/s13059-021-02401-3.
7
Psychological distance: a qualitative study of screening barriers among first-degree relatives of colorectal cancer patients.心理距离:结直肠癌患者一级亲属筛查障碍的定性研究。
BMC Public Health. 2021 Apr 13;21(1):716. doi: 10.1186/s12889-021-10786-w.
8
Autonomous and informed decision-making: The case of colorectal cancer screening.自主和知情决策:以结直肠癌筛查为例。
PLoS One. 2020 May 29;15(5):e0233308. doi: 10.1371/journal.pone.0233308. eCollection 2020.
9
Patients' views on involving general practice in bowel cancer screening: a South Australian focus group study.患者对全科医疗参与肠癌筛查的看法:一项南澳大利亚焦点小组研究
BMJ Open. 2020 May 18;10(5):e035244. doi: 10.1136/bmjopen-2019-035244.
10
The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens.样本类型和操作属性对不同结直肠癌筛查方案相对可接受性的影响。
Patient Prefer Adherence. 2018 Sep 18;12:1825-1836. doi: 10.2147/PPA.S172143. eCollection 2018.